The present disclosure relates to a method for modifying a DNA by utilizing a glycosylase and an oxyamine compound, and in particular to a method for modifying a functional DNA by utilizing a glycosylase and an oxyamine compound.
A functional DNA is a DNA with binding ability or catalytic activity, which is obtained through in vitro selection and folds to form a stable three-dimensional structure. Generally, functional DNAs include two categories: DNA aptamers and deoxyribozymes. The DNA aptamer can bind to a specific target, for example a protein, a small molecule and the like, and can be used for target detection and function regulation, etc. The deoxyribozyme can catalyze various chemical reactions, and can be applied in compound preparation, molecular detection and gene silencing, etc. The functional DNA has a wide range of application, such as disease diagnosis and treatment.
Although functional DNAs have many advantages and applications, the functions and applications of functional DNAs are still limited. One reason is that the nucleobases of natural DNAs have fewer functional groups compared to the side chains of amino acids, the basic building blocks of proteins. This problem can be solved by chemical modification of the DNA nucleobases to introduce more diverse chemical functional groups. An existing DNA modification method mainly uses means of synthetic chemistry to prepare monomers containing bases modified with various kinds of functional groups, and uses these DNA monomers containing modified bases in a solid phase synthesis process to finally produce a DNA strand containing a site-specific chemical modification. This method can introduce more functional groups into the DNA, but there are many steps in the synthesis method, and the required reaction conditions are relatively harsh, which limits the types of functional groups that can be synthesized, while the required material cost and time cost is high.
Objective of the present invention: an objective of the present disclosure is to provide a simple and easily accessible modification method with low cost and short time consumption for DNA modification.
Technical solution: a method for modifying a DNA with a glycosylase and an oxyamine compound according to the present invention, which includes the following steps:
The functional DNA modified by the specific oxyamine compound at a specific site can have better functionality.
Meanwhile, removal of various non-canonical bases and modification with various oxyamine compounds can be realized through orthogonal base-glycosylase pairs, achieving modification with various different oxyamine compounds at multiple sites of the same DNA strand.
Because the glycosylase that can be used in the present method can be a commercially available uracil DNA glycosylase, etc., and a commercially available common oxyamine compound can also be used as the oxyamine compound, the raw materials are easy to obtain.
The abasic site in the step (2) is a sugar ring without a base after treatment with the glycosylase. The incubation and separation time in the step (2) can be realized within 2 hours, and the reaction between the oxyamine compound and the DNA containing the abasic site in the step (3) is rapid and can be completed within half an hour, so the whole modification process can be completed quickly.
Different glycosylases specifically remove corresponding non-canonical bases in the DNA to obtain abasic sites. Multiple identical functional groups can be simultaneously introduced into multiple sites for modification by introducing multiple identical non-canonical bases into the same DNA strand. Multiple different non-canonical bases are introduced into the same DNA strand, and then the DNA strand is treated by using corresponding glycosylases and oxyamine compounds sequentially to obtain a DNA containing different modifications at different sites.
The non-canonical base in the step (1) includes one or more of the following: uracil, hypoxanthine, 3-methyladenine, 3-methylguanine, 7-methylguanine or oxoguanine, etc., and the glycosylase in the step (2) includes one or more of the following: a uracil DNA glycosylase, a methylated purine DNA glycosylase or a 8-oxoguanine DNA glycosylase, etc.
The step (1) specifically includes: designing a specific modification site and selecting a corresponding non-canonical base, and synthesizing a corresponding DNA single strand and a corresponding complementary DNA single strand.
The step (2) specifically includes: incubating the single strand synthesized in the step (1) with the corresponding glycosylase in a corresponding buffer for a certain period of time, and then separating the single strand from the glycosylase by an ethanol precipitation method. Alternatively, the single strand synthesized in the step (1) is annealed to a complementary strand carrying a biotin label to obtain a double strand, incubated with the corresponding glycosylase in the corresponding buffer for a certain time, and then the double strand is separated from the glycosylase by the ethanol precipitation method.
The step (3) specifically includes: incubating the DNA single strand or double strand carrying an abasic site obtained in the step (2) with an oxyamine compound in a buffer for a certain period of time. After the reaction, a modified DNA single strand is obtained by desalting the single strand directly with a desalting column, or alternatively a modified DNA single strand is obtained by using a streptavidin separation method on the modified DNA double strand.
Beneficial effect: compared with the prior art, the present disclosure has the following obvious advantages:
The technical solution of the present disclosure will be further explained in connection with specific examples hereafter.
As shown in
As shown in
As shown in
As shown in
Number | Date | Country | Kind |
---|---|---|---|
202110088599.9 | Jan 2021 | CN | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CN2021/097832 | 6/2/2021 | WO |